CSIMarket
 


Novocure Limited  (NVCR)
Other Ticker:  
 
 

NVCR's Revenue Growth by Quarter and Year

Novocure Limited's Revenue results by quarter and year




NVCR Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 133.21 143.95 99.23
III Quarter September 131.00 133.61 132.66 92.06
II Quarter June 140.87 133.52 115.93 86.71
I Quarter March 137.55 134.70 101.83 73.31
FY   409.42 535.04 494.37 351.31



NVCR Revenue third quarter 2022 Y/Y Growth Comment
Novocure Limited reported decrease in Revenue in the third quarter 2022 by -1.95% to $ 131.00 millions, from the same quarter in 2021.
The decrease in the third quarter 2022 Novocure Limited's Revenue compares unfavorably to the Company's average Revenue growth of 7.93%.

Looking into third quarter 2022 results within Medical Equipment & Supplies industry 22 other companies have achieved higher Revenue growth. While Novocure Limited' s Revenue decline of -1.95% ranks overall at the positon no. 752 in the third quarter 2022.




NVCR Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -7.46 % 45.07 % 42.43 %
III Quarter September -1.95 % 0.72 % 44.1 % 42.16 %
II Quarter June 5.5 % 15.17 % 33.7 % 40.97 %
I Quarter March 2.12 % 32.28 % 38.9 % 40.63 %
FY   - 8.23 % 40.72 % 41.62 %

Financial Statements
Novocure Limited's third quarter 2022 Revenue $ 131.00 millions NVCR's Income Statement
Novocure Limited's third quarter 2021 Revenue $ 133.61 millions Quarterly NVCR's Income Statement
New: More NVCR's historic Revenue Growth >>


NVCR Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -0.3 % 8.51 % 7.79 %
III Quarter September -7.01 % 0.07 % 14.43 % 6.17 %
II Quarter June 2.41 % -0.88 % 13.85 % 18.28 %
I Quarter March 3.26 % -6.43 % 2.62 % 5.22 %
FY (Year on Year)   - 8.23 % 40.72 % 41.62 %




Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #23
Healthcare Sector #76
Overall #752

Revenue Y/Y Growth Statistics
High Average Low
22.72 % 7.93 % -1.97 %
(Sep 30 2017)   (Dec 31 2021)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #23
Healthcare Sector #76
Overall #752
Revenue Y/Y Growth Statistics
High Average Low
22.72 % 7.93 % -1.97 %
(Sep 30 2017)   (Dec 31 2021)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Novocure Limited's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
39.53 % 9.88 % -7.01 %
(Dec 31 2016)  


NVCR's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Novocure Limited realized drop in Revenue sequentially by -7.01% to $ 131.00 millions, from $ 140.87 millions declared a quarter before.

Those cyclical circumstance that normally energize III. Quarter 2022 results, were not able to rescue the III. Quarter for the Novocure Limited, Cristina Santos, an industry veteran pointed out, she sees further headwinds down the road for Novocure Limited and wrote that average sequential Revenue growth is at 9.88% for Novocure Limited.

Within Medical Equipment & Supplies industry 27 other companies have achieved higher Revenue quarter on quarter growth. While Novocure Limited's Revenue growth quarter on quarter, overall rank is 788.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #28
Healthcare Sector #94
Overall #788
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #28
Healthcare Sector #94
Overall #788
Revenue Q/Q Growth Statistics
High Average Low
39.53 % 9.88 % -7.01 %
(Dec 31 2016)  


NVCR's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2022 Novocure Limited reported drop in Revenue from the second quarter by -7.01% to $ 131.00 millions, from $ 140.87 millions released in the previous quarter.

Even cyclical circumstance which normally energize III. Quarter 2022 performance, could not recover the III. Quarter for the Novocure Limited, Cristina Santos, an industry veteran said, she sees further challenges down the road for Novocure Limited.

Within Medical Equipment & Supplies industry 27 other companies have achieved higher Revenue quarter on quarter growth. While Novocure Limited's Revenue growth quarter on quarter, overall rank is 788.


Novocure Limited's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Revenue 12 Months Ending $ 542.62 $ 545.23 $ 537.88 $ 535.03 $ 545.77
Y / Y Revenue Growth (TTM) -0.58 % 0.07 % 2.02 % 8.23 % 21.38 %
Year on Year Revenue Growth Overall Ranking # 757 # 492 # 503 # 1707 # 905
Seqeuential Revenue Change (TTM) -0.48 % 1.37 % 0.53 % -1.97 % 0.17 %
Seq. Revenue Growth (TTM) Overall Ranking # 752 # 406 # 468 # 2187 # 2781




Cumulative Revenue growth Comment
For the 12 months ended Sep 30 2022 Novocure Limited reported a decrease in Revenue by -0.58% year on year, to $543 millions, compare to the 0.07% growth at Jun 30 2022.

In the Healthcare sector 82 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 492 to 757.

Revenue TTM Q/Q Growth Statistics
High Average Low
22.72 %
7.93 %
-1.97 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 23
Healthcare Sector # 83
Overall # 757

Revenue TTM Y/Y Growth Statistics
High Average Low
304.15 %
60.8 %
-0.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 76
S&P 500 # 752
Cumulative Revenue growth Comment
For the 12 months ended Sep 30 2022 Novocure Limited reported a decrease in Revenue by -0.58% year on year, to $543 millions, compare to the 0.07% growth at Jun 30 2022.

In the Healthcare sector 82 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 492 to 757.

Revenue TTM Q/Q Growth Statistics
High Average Low
22.72 %
7.93 %
-1.97 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 23
Healthcare Sector # 83
Overall # 757

Revenue TTM Y/Y Growth Statistics
High Average Low
304.15 %
60.8 %
-0.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 23
Sector # 76
S&P 500 # 752




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NVCR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NVCR's Competitors
Revenue Growth for Novocure Limited's Suppliers
Revenue Growth for NVCR's Customers

You may also want to know
NVCR's Annual Growth Rates NVCR's Profitability Ratios NVCR's Asset Turnover Ratio NVCR's Dividend Growth
NVCR's Roe NVCR's Valuation Ratios NVCR's Financial Strength Ratios NVCR's Dividend Payout Ratio
NVCR's Roa NVCR's Inventory Turnover Ratio NVCR's Growth Rates NVCR's Dividend Comparisons



Companies with similar Revenue decrease for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2022
Owens and Minor Inc -0.19%$ -0.191 millions
National Research Corporation-0.20%$ -0.201 millions
Livanova Plc-0.24%$ -0.241 millions
Healthcare Services Group Inc -0.27%$ -0.265 millions
Catalent Inc -0.29%$ -0.293 millions
Asensus Surgical Inc -0.31%$ -0.311 millions
Liquidia Corporation-0.43%$ -0.429 millions
Integra Lifesciences Holdings Corp-0.43%$ -0.432 millions
Pediatrix Medical Group Inc -0.62%$ -0.615 millions
China Pharma Holdings Inc -0.64%$ -0.642 millions
Acadia Pharmaceuticals Inc -0.68%$ -0.682 millions
Syneos Health Inc -0.89%$ -0.891 millions
Innovage Holding Corp -1.07%$ -1.070 millions
Procyon Corp-1.20%$ -1.200 millions
Precipio inc -1.38%$ -1.380 millions
Ati Physical Therapy Inc -1.40%$ -1.397 millions
Ocular Therapeutix Inc -1.55%$ -1.547 millions
Alpine Immune Sciences Inc -1.75%$ -1.750 millions
Surgalign Holdings Inc -1.79%$ -1.786 millions
Tenet Healthcare Corp-1.90%$ -1.900 millions
Teleflex Incorporated-1.92%$ -1.923 millions
Novocure Limited-1.95%$ -1.952 millions
Dynatronics Corporation-2.01%$ -2.014 millions
Royalty Pharma Plc-2.10%$ -2.101 millions
National Healthcare Corp-2.13%$ -2.130 millions
Fonar Corporation-2.27%$ -2.271 millions
Psychemedics Corp-2.35%$ -2.353 millions
Escalon Medical Corp -2.63%$ -2.626 millions
Lifevantage Corp-2.72%$ -2.724 millions
West Pharmaceutical Services Inc -2.77%$ -2.774 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

INBS's Profile

Stock Price

INBS's Financials

Business Description

Fundamentals

Charts & Quotes

INBS's News

Suppliers

INBS's Competitors

Customers & Markets

Economic Indicators

INBS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071